Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pharmacology Research & Perspectives|March 30, 2016
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistRachel Garner, Shobha Gopalakrishnan, John A McCauley, et al.
Clinical Pharmacology and Therapeutics|December 24, 2019
Fine-Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus InfectionWei Gao, Andrea L Webber, Jill Maxwell, et al.
Journal of the American Chemical Society|March 15, 2008
Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A proteaseNigel J Liverton, M Katharine Holloway, John A McCauley, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2010
Synthesis and evaluation of a new series of Neuropeptide S receptor antagonistsJeffrey Y Melamed, Amy E Zartman, Nathan R Kett, et al.
Gastroenterology|April 15, 2014
The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis C virus genotype 1 infection without cirrhosisMichael P Manns, John M Vierling, Bruce R Bacon, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in ratsIan M Bell, Craig A Stump, Steven N Gallicchio, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy VolunteersHwa-Ping Feng, Luzelena Caro, Christine Fandozzi, et al.
ACS Chemical Neuroscience|July 21, 2012
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonistsMark E Layton, Michael J Kelly, Kevin J Rodzinak, et al.
Bioanalysis|December 7, 2019
2019 White Paper on Recent Issues in Bioanalysis: Chromatographic Assays (Part 1 - Innovation in Small Molecules and Oligonucleotides & Mass Spectrometric Method Development Strategies for Large Molecule Bioanalysis)Christine Fandozzi, Christopher Evans, Amanda Wilson, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Pageof 3